Zala Megyei Szent Rafael Korhaz
About Zala Megyei Szent Rafael Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
6
Allergan
5
Pfizer
5
Bayer
4
Boehringer Ingelheim
3
Hoffmann-La Roche
3
EMD Serono Research & Development Institute, Inc.
2
Faraday Pharmaceuticals, Inc.
2
Gan and Lee Pharmaceuticals, USA
2
Gilead Sciences
2
Janssen Research & Development, LLC
2
Clinical Trials at Zala Megyei Szent Rafael Korhaz
During the past decade, Zala Megyei Szent Rafael Korhaz conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 28 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 18 clinical trials were completed. i.e. 138.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
2008-01-01
2010-06-24
Completed
201
Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III
2008-03-01
2012-02-01
Completed
1,902
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
2011-03-01
2021-12-01
Unknown status
1,000
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
2008-11-01
2012-08-01
Completed
742
Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)
2008-06-01
Completed
317
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
2009-12-01
2012-04-01
Terminated
446
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Zala Megyei Szent Rafael Korhaz" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Allergan" with 5 trials
sponsored, "Pfizer" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Boehringer Ingelheim"
with 4 trials sponsored. Other sponsors include 34 different institutions and
companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zala Megyei Szent Rafael Korhaz"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Zala Megyei Szent Rafael Korhaz
According to Clinical.Site data, the most researched conditions in "Zala Megyei Szent Rafael Korhaz" are
"Diabetes Mellitus, Type 2" (5 trials), "Gastroparesis" (4 trials), "Myocardial Infarction" (4 trials), "Type 2 Diabetes Mellitus" (4 trials) and "Acute Myocardial Infarction" (3 trials). Many other conditions were trialed in "Zala Megyei Szent Rafael Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Zala Megyei Szent Rafael Korhaz
Most popular intervention types in "Zala Megyei Szent Rafael Korhaz" are "Drug" (55 trials), "Other" (10 trials), "Biological" (6 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Carboplatin" (4 trials), "Avelumab" (3 trials), "Cisplatin" (3 trials) and "Dulaglutide" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Zala Megyei Szent Rafael Korhaz
The vast majority of trials in "Zala Megyei Szent Rafael Korhaz" are
57 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at Zala Megyei Szent Rafael Korhaz
Currently, there are NaN active trials in "Zala Megyei Szent Rafael Korhaz".
undefined are not yet recruiting,
7 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 35 completed trials in Zala Megyei Szent Rafael Korhaz,
1 suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Zala Megyei Szent Rafael Korhaz, 1 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 41 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 2 trials that are defined as “Not Applicable".
Departments of Zala Megyei Szent Rafael Korhaz
Zala Megyei Szent Rafael Korhaz has several departments that took part in Clinical trials: "Zala Megyei Kórház,Kardiológia" - 2 trials
Departments List
Name
City
Trials